Celldex Therapeutics, Inc. Share Price
NASDAQ: CLDX | Mid CapCelldex Therapeutics, Inc. Stock Performance
Open $41.51 | Prev. Close $41.70 | Circuit Range N/A |
Day Range $41.51 - $43.13 | Year Range $19.73 - $43.13 | Volume 33,372 |
Average Traded $42.51 |
Celldex Therapeutics, Inc. Share Price Today
As of 11 August 2026, Celldex Therapeutics, Inc.'s share price is $42.98. The stock opened at $41.51, compared to its previous close of $41.70. During today's trading session, Celldex Therapeutics, Inc.'s share price traded between $41.51 and $43.13, with an average price of $42.32. Over the past 52 weeks, the stock has recorded a high of $43.13 and a low of $19.73. In terms of performance, Celldex Therapeutics, Inc.'s share price has risen by 42.74% over the last six months and is up 94.92% on a year-on-year basis.
Celldex Therapeutics, Inc. Share Price Chart
Celldex Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.85B | PE Ratio (TTM) -11.02 | Dividend Yield N/A |
EPS (TTM) $-3.90 | Revenue (TTM) $1.54M | Return On Equity (TTM) -49.08% |
Profit Margin -16748.03% | Debt to Equity 0.10 | Quarterly Earnings Growth YoY N/A |
Celldex Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Celldex Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
Celldex Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $37.93 | $42.94 | +12.79% |
Jul 2026 | $37.35 | $38.07 | +2.41% |
Jun 2026 | $30.95 | $37.17 | +18.43% |
May 2026 | $33.43 | $31.39 | -4.50% |
Apr 2026 | $32.12 | $32.87 | +3.67% |
Mar 2026 | $29.72 | $31.70 | +5.30% |
Feb 2026 | $24.59 | $30.11 | +22.25% |
Jan 2026 | $27.03 | $24.63 | -9.32% |
Dec 2025 | $26.48 | $27.16 | +0.56% |
Nov 2025 | $26.63 | $27.01 | +1.16% |
Oct 2025 | $25.84 | $26.70 | +3.17% |
Sep 2025 | $21.89 | $25.88 | +17.37% |
CLDX Share Price FAQs
What is Celldex Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Celldex Therapeutics, Inc. stock?
What is CLDX's market capitalisation today?
What is CLDX's net income for the last quarter?
What is the 5 year returns of CLDX?
What is the high & low stock price of CLDX today?
Can I buy CLDX shares in India?